Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,291.20
(
0.66%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.50
(
-0.15%
)
Bitcoin
74,225.69
(
0.39%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RockRat post# 113972

Thursday, 02/03/2011 1:22:25 PM

Thursday, February 03, 2011 1:22:25 PM

Post# of 257253
The salient point, IMO, is that ItalFarmaco does not have separate enoxaparin products for Lupin and Teva; rather, it has one enoxaparin for both clients. Lupenox has probably changed to some degree in the five years since it was launched in India, so your posts about the makeup of Lupenox circa 2006 are not probative in the way you imagine them to be. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now